BioGenix Email Format
Biotechnology ResearchTexas, United States11-50 Employees
BioGenix is a Houston-based biotechnology company focused on regenerative medicine that relies on umbilical cord tissue–derived products. It works directly with hospitals participating in umbilical cord tissue donation programs and partners with a sterile FDA-registered laboratory to translate concept into clinically available options for physicians. By using growth-factor–rich cord tissue, the company aims to provide therapies that avoid invasive procedures while adhering to ethical considerations. The enterprise emerged from a recognition of the potential of regenerative medicine to assist patients with past injuries, chronic conditions, or degenerative diseases. Its offerings are intended for physicians across multiple medical specialties, enabling regenerative solutions for domestic and international markets. In January 2026, Dr. Reddy’s Laboratories announced a partnership with BioGenix to develop and commercialize a novel CAR-T cell therapy.